AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2025
Dec 23, 2025
33090_dirs_2025-12-23_56987b21-6ec4-41fa-b5f0-35fdd038d113.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-12-23
Reporting Person: Silvestro Stephen L (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Common Stock | F | 3361 | $12.74 | Disposed | 190507 | Direct |
More from OptimizeRx Corp
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 12
Board/Management Information
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23